Ropeginterferon Alfa-2b: Efficacy and Safety in Different Age Groups - Heinz Gisslinger; Christoph Klade; Pencho Georgiev; Dorota Krochmalczyk; Liana Gercheva-Kyuchukova; Miklos Egyed; Viktor Rossiev; Petr Dulicek; Arpad Illes; Halyna Pylypenko; Lylia Sivcheva; Jiri Mayer; et al. (HemaSphere, 2020)